Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03881943

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03881943
Other papers using this trial's data
  • Multi-Omics Signatures Link to Ticagrelor Effects on Vascular Function in Patients With Acute Coronary Syndrome Arteriosclerosis, thrombosis, and vascular biology, 2022-06 DOI, PubMed 35387483

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03881943. Randomized; double masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2018-12-21 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS
Acronym
FMD_ACS
Condition
Acute Coronary Syndrome
Intervention (Drug)
Ticagrelor 60 mg
Intervention (Drug)
Aspirin 100 MG Oral Tablet, Enteric Coated
Lead sponsor
The University of Hong Kong (class: other)

Record details

Record id
cardio:ct-nct03881943
Content hash
4d80eaae1344d12954a727ba0b359aaf6c475aed5b3b0fb2ef9776734ef97de3